Chinese University Of Hong Kong
Clinical trials sponsored by Chinese University Of Hong Kong, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Could a daily synbiotic supplement ease ulcerative colitis? Results expected Sep 2026 (estimated)
- Meningitis b vaccine tested as gonorrhea shield in men Results expected Sep 2026 (estimated)
- AI may help spot dangerous prostate cancer and spare men from needless biopsies Results expected Sep 2026 (estimated)
- Heart damage in fabry disease: new study tracks silent progression Results expected Sep 2026 (estimated)
- Stent may prevent deadly complications after aortic tear surgery Results expected Sep 2026 (estimated)
-
Can an ancient herbal remedy ease swelling in the eye?
Disease control Stopped earlyThis phase 2 trial tests whether a modified Chinese herbal formula, Shenling Baizhu San, can reduce swelling in the retina (macular edema) and improve vision. Adults diagnosed with macular edema take either the herbal granules or a placebo twice daily for 12 weeks. The study meas…
Phase 2 • Sponsor: Chinese University of Hong Kong • Aim: Disease control
Last updated Jul 29, 2026 00:00 UTC
-
Radioactive microparticles injected into pancreatic tumors: a new hope?
Disease control Stopped earlyThis study aimed to see if injecting radioactive particles (OncoSil) directly into pancreatic tumors during an endoscopic ultrasound, combined with chemotherapy, could safely shrink tumors and improve survival. It was designed for people with advanced pancreatic cancer that could…
Phase 2/3 • Sponsor: Chinese University of Hong Kong • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC